Urban Paulsson

Member of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
2
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Jun 2, 2017 – Apr 12, 2023

Urban Paulsson reported 11 transactions between Jun 2, 2017 and Apr 12, 2023. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
95.63B SEK
5 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
11
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought Lipigon Pharmaceuticals AB shares worth 435,256 SEK between Jun 21, 2021 and Jun 23, 2021

Cluster buying

4 different insiders made 7 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

4 insiders bought Lipigon Pharmaceuticals AB shares worth 435,256 SEK between Jun 21, 2021 and Jun 23, 2021
Date Insider Transaction Shares Price Value Filing
Jun 21, 2021 Michael James Owens SACQ Acquisition 10,000 6.75 SEK 67,500 SEK FI filing ↗
Jun 21, 2021 Urban Paulsson SACQ Acquisition 16,171 6.99 SEK 113,039 SEK FI filing ↗
Jun 21, 2021 Jessica Marie Martinsson SACQ Acquisition 8,000 6.61 SEK 52,880 SEK FI filing ↗
Jun 21, 2021 Jessica Marie Martinsson SACQ Acquisition 1,000 6.94 SEK 6,940 SEK FI filing ↗
Jun 21, 2021 Jessica Marie Martinsson SACQ Acquisition 1,000 6.88 SEK 6,880 SEK FI filing ↗
Jun 23, 2021 Urban Paulsson SACQ Acquisition 20,000 7.40 SEK 148,080 SEK FI filing ↗
Jun 23, 2021 Eva Arlander SACQ Acquisition 5,325 7.50 SEK 39,938 SEK FI filing ↗

Total of the rows above: 435,256 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 11 most recent rows are grouped into 11 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Lipigon Pharmaceuticals AB SSUB Subscriptionnot a buy/sell decision 114,286 shares 400.0K SEK at 3.50 SEK FI filing ↗
  2. Lipigon Pharmaceuticals AB SSUB Subscriptionnot a buy/sell decision 398,430 shares 856.6K SEK at 2.15 SEK FI filing ↗
  3. Nanexa AB SACQ Acquisition 60,000 shares 300.0K SEK at 5.00 SEK FI filing ↗
  4. Lipigon Pharmaceuticals AB SACQ Acquisition 20,000 shares 148.1K SEK at 7.40 SEK FI filing ↗
  5. Lipigon Pharmaceuticals AB SACQ Acquisition 16,171 shares 113.0K SEK at 6.99 SEK FI filing ↗
  6. Camurus AB SEXD Exercise decreasenot a buy/sell decisionreported at zero 75,000 shares 0 SEK at 0.00 SEK FI filing ↗
  7. Camurus AB SACQ Acquisition 30,000 shares 1.34M SEK at 44.70 SEK FI filing ↗
  8. Nanexa AB SALL Allotmentnot a buy/sell decision 106,000 shares 121.9K SEK at 1.15 SEK FI filing ↗
  9. Camurus AB SALL Allotmentnot a buy/sell decision 1,625 shares 68.3K SEK at 42.00 SEK FI filing ↗
  10. Camurus AB SALL Allotmentnot a buy/sell decision 40,000 shares 513.2K SEK at 12.83 SEK FI filing ↗
  11. Camurus AB SACQ Acquisition 75,000 shares 95.63B SEK at 1,275,000.00 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Camurus AB SE0007692850 CAMURUS AB 1,625 — — FI marknadssok.fi.se ↗
Lipigon Pharmaceuticals AB SE0015382072 Lipigon Pharmaceuticals AB (indirect) 36,171 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Urban Paulsson reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.